In our latest activity report, we looked back to the exceptional year of 2020, and how it impacted the generic veterinary medicines sector, our members and our activities. We gathered a few highlights and challenges encountered and tackled, as well as revealed some of the progress our working groups achieved in different fora, not least how they contributed to the new EU veterinary medicines legislation.

Read more in the report.